A blog about chemistry, drug development, science, and technology
The AnorMED / Genzyme / Millennium saga continues. Now Genzyme has raised their hostile bid to acquire AnorMED. Genzyme’s new bid is $580 million.
Genzyme Raises Bid in AnorMed Fight: Financial News - Yahoo! Finance
AnorMED has until 4 PM PDT Oct. 11 to decide on Genzyme’s offer.
This one is interesting to watch and I personally think the smartest suitor will be the one who pulls out. This sort of bidding war only serves to help AnorMed and make it a very expensive proposition for whomever ends up acquiring them. This isn’t the end of this and it will be interesting to see how this plays out through the ned of the month.
As I have stated before, the merger and acquisition activity is showing no signs of slowing down any time soon. If anything, it is just now building up pa good head of steam.
Disclosure: I own a few shares of Millennium
Other Resources
News Stories
Blog Posting
Technorati Tags: Anormed, Genzyme, Millennium, pharma M&A, pharmaceutical deals
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.042 seconds